Alpha Tau Medical Ltd (DRTS)

Alpha Tau Medical experienced significant insider trading activity recently, with CFO Raphi Levy executing seventeen sell transactions totaling approximately 1.27 million dollars. These divestments occurred alongside a 33.2% stock price increase over ninety days. Following the latest results financiers, the equity currently trades near its fifty-two week peak.
Ticker: DRTS Exchange: NAS


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Alpha Tau Medical Ltd. Upgrade to see score, net flow, insiders and the full signal context.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Levy Raphi Chief Financial Officer Officer
Transaction date
Sale
Price
463.45
Quantity 3,381 -45.8%
Value US$632,529
Levy Raphi Chief Financial Officer Officer
Transaction date
Sale
Price
436.21
Quantity 63,268 -6.1%
Value US$4,633,431
Levy Raphi Officer Officer
Transaction date
Proposed sale
Price
36.76
Quantity 54,223
Value US$2,269,140
Levy Raphi Chief Financial Officer Officer
Transaction date
Sale
Price
13.00
Quantity 17,873 -16.5%
Value US$232,397
Levy Raphi Chief Financial Officer Officer
Transaction date
Sale
Price
13.02
Quantity 2,127 -2.3%
Value US$27,691
Levy Raphi Officer Officer
Transaction date
Proposed sale
Price
12.58
Quantity 20,000
Value US$251,600
Levy Raphi Chief Financial Officer Officer
Transaction date
Sale
Price
12.00
Quantity 20,000 -18.2%
Value US$240,044
Levy Raphi Officer Officer
Transaction date
Proposed sale
Price
11.22
Quantity 20,000
Value US$224,400
Levy Raphi Chief Financial Officer Officer
Transaction date
Sale
Price
11.00
Quantity 15,778 -12.5%
Value US$173,561
Levy Raphi Chief Financial Officer Officer
Transaction date
Sale
Price
11.00
Quantity 4,222 -3.2%
Value US$46,443
Levy Raphi Officer Officer
Transaction date
Proposed sale
Price
10.05
Quantity 20,000
Value US$201,000
Levy Raphi Chief Financial Officer Officer
Transaction date
Sale
Price
10.00
Quantity 2,500 -1.9%
Value US$25,001
Levy Raphi Chief Financial Officer Officer
Transaction date
Sale
Price
9.47
Quantity 15,000 -10.2%
Value US$142,050
Levy Raphi Officer Officer
Transaction date
Proposed sale
Price
10.03
Quantity 17,500
Value US$175,525
Levy Raphi Chief Financial Officer Officer
Transaction date
Sale
Price
10.76
Quantity 15,000 -9.2%
Value US$161,356
Levy Raphi Chief Financial Officer Officer
Transaction date
Sale
Price
10.90
Quantity 17,500 -9.7%
Value US$190,759
Levy Raphi Officer Officer
Transaction date
Proposed sale
Price
8.93
Quantity 32,500
Value US$290,225
Levy Raphi Officer Officer
Transaction date
Proposed sale
Price
7.40
Quantity 10,000
Value US$73,950
Gat Amnon Officer Officer
Transaction date
Proposed sale
Price
6.94
Quantity 87,010
Value US$603,849
Levy Raphi Officer Officer
Transaction date
Proposed sale
Price
7.09
Quantity 15,000
Value US$106,350
Levy Raphi Officer Officer
Transaction date
Proposed sale
Price
6.41
Quantity 25,000
Value US$160,250
Gat Amnon Officer Officer
Transaction date
Proposed sale
Price
5.90
Quantity 61,745
Value US$364,296
Levy Raphi Officer Officer
Transaction date
Proposed sale
Price
5.90
Quantity 20,000
Value US$118,000
Gat Amnon Officer Officer
Transaction date
Proposed sale
Price
4.23
Quantity 60,092
Value US$254,189
Gat Amnon Officer Officer
Transaction date
Proposed sale
Price
3.97
Quantity 16,000
Value US$63,520
Gat Amnon Officer Officer
Transaction date
Proposed sale
Price
4.17
Quantity 16,000
Value US$66,640
Gat Amnon Officer Officer
Transaction date
Proposed sale
Price
4.51
Quantity 16,000
Value US$72,160
Keisari Yona Officer Officer
Transaction date
Proposed sale
Price
2.92
Quantity 22,602
Value US$65,998
Keisari Yona Officer Officer
Transaction date
Proposed sale
Price
2.81
Quantity 23,615
Value US$66,358
Althera Medical Ltd. 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
4.25
Quantity 3,393
Value US$14,420
Althera Medical Ltd. 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
4.60
Quantity 1,424
Value US$6,550
Althera Medical Ltd. 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
4.60
Quantity 7,471
Value US$34,366
Althera Medical Ltd. 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
4.70
Quantity 21,631
Value US$101,665
Althera Medical Ltd. 10% Stockholder Large shareholder
Transaction date
Proposed sale
Price
4.19
Quantity 60,000
Value US$251,532
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2026-08-12 2026-08-11 S Sale

Chief Financial Officer

Officer
3,381 -45.8%
463.45
US$632,529
3,381 -45.8% 463.45 US$632,529
2026-07-07 2026-07-06 S Sale

Chief Financial Officer

Officer
63,268 -6.1%
436.21
US$4,633,431
63,268 -6.1% 436.21 US$4,633,431
2026-07-06 2026-07-06 PrS Proposed sale

Officer

Officer
54,223
36.76
US$2,269,140
54,223 36.76 US$2,269,140
2026-07-06 2026-07-02 S Sale

Chief Financial Officer

Officer
17,873 -16.5%
13.00
US$232,397
17,873 -16.5% 13.00 US$232,397
2026-07-02 2026-07-01 S Sale

Chief Financial Officer

Officer
2,127 -2.3%
13.02
US$27,691
2,127 -2.3% 13.02 US$27,691
2026-07-02 2026-07-01 PrS Proposed sale

Officer

Officer
20,000
12.58
US$251,600
20,000 12.58 US$251,600
2026-07-01 2026-06-30 S Sale

Chief Financial Officer

Officer
20,000 -18.2%
12.00
US$240,044
20,000 -18.2% 12.00 US$240,044
2026-06-30 2026-06-30 PrS Proposed sale

Officer

Officer
20,000
11.22
US$224,400
20,000 11.22 US$224,400
2026-06-26 2026-06-25 S Sale

Chief Financial Officer

Officer
15,778 -12.5%
11.00
US$173,561
15,778 -12.5% 11.00 US$173,561
2026-06-26 2026-06-25 S Sale

Chief Financial Officer

Officer
4,222 -3.2%
11.00
US$46,443
4,222 -3.2% 11.00 US$46,443
2026-06-26 2026-06-25 PrS Proposed sale

Officer

Officer
20,000
10.05
US$201,000
20,000 10.05 US$201,000
2026-06-25 2026-06-23 S Sale

Chief Financial Officer

Officer
2,500 -1.9%
10.00
US$25,001
2,500 -1.9% 10.00 US$25,001
2026-06-25 2026-06-23 S Sale

Chief Financial Officer

Officer
15,000 -10.2%
9.47
US$142,050
15,000 -10.2% 9.47 US$142,050
2026-06-23 2026-06-23 PrS Proposed sale

Officer

Officer
17,500
10.03
US$175,525
17,500 10.03 US$175,525
2026-06-04 2026-06-03 S Sale

Chief Financial Officer

Officer
15,000 -9.2%
10.76
US$161,356
15,000 -9.2% 10.76 US$161,356
2026-06-04 2026-06-03 S Sale

Chief Financial Officer

Officer
17,500 -9.7%
10.90
US$190,759
17,500 -9.7% 10.90 US$190,759
2026-06-04 2026-06-03 PrS Proposed sale

Officer

Officer
32,500
8.93
US$290,225
32,500 8.93 US$290,225
2026-02-26 2026-02-25 PrS Proposed sale

Officer

Officer
10,000
7.40
US$73,950
10,000 7.40 US$73,950
2026-02-02 2026-02-02 PrS Proposed sale

Officer

Officer
87,010
6.94
US$603,849
87,010 6.94 US$603,849
2026-01-14 2026-01-13 PrS Proposed sale

Officer

Officer
15,000
7.09
US$106,350
15,000 7.09 US$106,350
2026-01-12 2026-01-09 PrS Proposed sale

Officer

Officer
25,000
6.41
US$160,250
25,000 6.41 US$160,250
2026-01-09 2026-01-08 PrS Proposed sale

Officer

Officer
61,745
5.90
US$364,296
61,745 5.90 US$364,296
2026-01-09 2026-01-08 PrS Proposed sale

Officer

Officer
20,000
5.90
US$118,000
20,000 5.90 US$118,000
2025-12-11 2025-12-10 PrS Proposed sale

Officer

Officer
60,092
4.23
US$254,189
60,092 4.23 US$254,189
2025-12-01 2025-12-01 PrS Proposed sale

Officer

Officer
16,000
3.97
US$63,520
16,000 3.97 US$63,520
2025-11-03 2025-11-03 PrS Proposed sale

Officer

Officer
16,000
4.17
US$66,640
16,000 4.17 US$66,640
2025-10-01 2025-10-01 PrS Proposed sale

Officer

Officer
16,000
4.51
US$72,160
16,000 4.51 US$72,160
2024-03-15 2024-03-14 PrS Proposed sale

Officer

Officer
22,602
2.92
US$65,998
22,602 2.92 US$65,998
2023-12-18 2023-12-15 PrS Proposed sale

Officer

Officer
23,615
2.81
US$66,358
23,615 2.81 US$66,358
2023-06-09 2023-06-09 PrS Proposed sale

10% Stockholder

Large shareholder
3,393
4.25
US$14,420
3,393 4.25 US$14,420
2023-06-08 2023-06-08 PrS Proposed sale

10% Stockholder

Large shareholder
1,424
4.60
US$6,550
1,424 4.60 US$6,550
2023-06-08 2023-06-07 PrS Proposed sale

10% Stockholder

Large shareholder
7,471
4.60
US$34,366
7,471 4.60 US$34,366
2023-06-06 2023-06-06 PrS Proposed sale

10% Stockholder

Large shareholder
21,631
4.70
US$101,665
21,631 4.70 US$101,665
2023-06-02 2023-06-02 PrS Proposed sale

10% Stockholder

Large shareholder
60,000
4.19
US$251,532
60,000 4.19 US$251,532